AVALO THERAPEUTICS, INC. Acquisitions, Net of Cash Acquired
AVALO THERAPEUTICS, INC. (AVTX) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2020-03-11
- AVALO THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-12-31 was $0.00.
- AVALO THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-09-30 was $0.00.
- AVALO THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-06-30 was $0.00.
- AVALO THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- AVALO THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- AVALO THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2018 was $1.00, a 100.00% decline from fiscal 2017.
- AVALO THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2017 was $18.89M.
- AVALO THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2016 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $0.00 derived: sum of 2 quarters · filed 2020-03-11 | $0.00 derived: sum of 3 quarters · filed 2020-03-11 | $0.00 10-K · filed 2020-03-11 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | $0.00 derived: sum of 3 quarters · filed 2020-03-11 | $0.00 derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2020-03-11 | $0.00 derived: sum of 3 quarters · filed 2020-03-11 | $0.00 derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $0.00 derived: sum of 2 quarters · filed 2020-03-11 | $0.00 derived: sum of 3 quarters · filed 2020-03-11 | $1.00 10-K · filed 2020-03-11 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $1.00 10-Q · filed 2019-11-14 | $18.89M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.00 10-Q · filed 2019-08-08 | $18.89M derived: sum of 3 quarters · filed 2019-08-08 | $18.89M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $1.00 10-Q · filed 2019-05-09 | $18.89M derived: sum of 2 quarters · filed 2019-05-09 | $18.89M derived: sum of 3 quarters · filed 2019-05-09 | $18.89M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $18.89M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $18.89M derived: sum of 2 quarters · filed 2018-11-13 | $18.89M derived: sum of 3 quarters · filed 2018-11-13 | $18.89M 10-K · filed 2018-04-02 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-11 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |